Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
ClinicalTrials.gov study NCT02439788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05577000. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia
ClinicalTrials.gov study NCT04923919. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
ClinicalTrials.gov study NCT06071624. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
ClinicalTrials.gov study NCT07244666. IPD Sharing: NO. Countries: 1. Publications: 0.
Blood Samples to Evaluate Biomarkers of Donor Chimerism
ClinicalTrials.gov study NCT00764829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03850418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
ClinicalTrials.gov study NCT07283315. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.
ClinicalTrials.gov study NCT03614858. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects
ClinicalTrials.gov study NCT05277987. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
ClinicalTrials.gov study NCT07193628. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of CD38\CS1 Chimeric Antigen Receptor T Cells in the Treatment of Refractory/Recurrent Multiple Myeloma
ClinicalTrials.gov study NCT06574958. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
ClinicalTrials.gov study NCT06839976. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma
ClinicalTrials.gov study NCT01459887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
ClinicalTrials.gov study NCT07148050. IPD Sharing: NO. Countries: 1. Publications: 0.
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
ClinicalTrials.gov study NCT06340737. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
ClinicalTrials.gov study NCT06789081. IPD Sharing: NO. Countries: 0. Publications: 0.
Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leuke
ClinicalTrials.gov study NCT07166419. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
ClinicalTrials.gov study NCT05648019. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment
ClinicalTrials.gov study NCT05381662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.